Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Nippon Shinyaku DMD Med Gets FDA’s Rare Pediatric Disease Tag
September 9, 2024
- Takeda’s Plasma Therapy Ceprotin Now Available in Japan
September 9, 2024
- Japan Ethical Drug Sales Up 9.6% in July: Crecon
September 9, 2024
- Axcelead DDP, Lilly Ink Research Collaboration Pact
September 6, 2024
- JN.1-Targeting Nuvaxovid Approved in Japan: Takeda
September 6, 2024
- Keytruda Nabs Best-Seller Drug Title for 11th Straight Month: Encise
September 6, 2024
- Organon’s OG-8276A for Dysmenorrhea Hits Goal in Japan PIII Study
September 5, 2024
- Daiichi Sankyo Wins Japan Approval for Updated COVID Jab for JN.1
September 5, 2024
- Kissei Snares Rigel’s AML Therapy in Japan, Korea, Taiwan
September 5, 2024
- Kidswell Is Open to M&As Amid Challenging Financing Environment: CEO
September 4, 2024
- PDRadiopharma’s PET Imaging Agent Amyvid Widens Label Too
September 4, 2024
- Asahi Kasei Closes Tender Offer for Calliditas, Enriches Renal Franchise
September 4, 2024
- Stella Pharma, NCC, Sumitomo Heavy Industries Tie Up in BNCT Basket Trial
September 4, 2024
- Aculys Pharma Files Diazepam Nasal Spray in Japan
September 3, 2024
- PET Agent Vizamyl Approved for Use in Patients on Anti-Aβ Therapy
September 3, 2024
- Nichi-Iko to Finally Roll Out Halaven AG Nearly 4 Years after Approval
September 3, 2024
- Ex-Sanofi Exec John Pulvar Tapped as New CEO of Ferring Japan
September 3, 2024
- BMS Aspires to Double Japan Sales over Next Decade with 5 Growth Drivers
September 3, 2024
- RaQualia’s Acid Reducer Tegoprazan Approved in Colombia
September 3, 2024
- Janssen Offloads Nizoral Cream to Teikoku Seiyaku
September 3, 2024
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…